News & Perspective

Nov 30, 2007

Nov 30, 2007

UN: H5N1 responses improving, but threat persists

(CIDRAP News) – Many countries have improved their responses to H5N1 avian influenza outbreaks in poultry in the past year, but the disease remains entrenched in six countries, according to a new report from the United Nations and the World Bank.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 31, 2007

Oct 31, 2007

THE PANDEMIC VACCINE PUZZLE Part 5: What role for prepandemic vaccination?

Editor's note: This is the fifth in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

Aug 07, 2007

Aug 07, 2007

WHO: Indonesia's withholding of viruses endangers world

(CIDRAP News) – A World Health Organization official said yesterday that Indonesia is endangering the world's health by continuing to withhold H5N1 influenza virus samples collected from human patients.

Jun 13, 2007

Jun 13, 2007

Glaxo to give 50 million doses of H5N1 vaccine to WHO

(CIDRAP News) – GlaxoSmithKline (GSK) promised today to give 50 million doses of its H5N1 "prepandemic" influenza vaccine to the World Health Organization (WHO) for distribution to poor countries.

The vaccine will be delivered over 3 years and be enough to vaccinate 25 million people at two doses each, the United Kingdom–based drug company said in a news release.

Feb 14, 2007

Feb 14, 2007

Egypt reports 3rd H5N1 case of 2007

(CIDRAP News) – Egypt’s health ministry today announced that a 37-year-old woman has tested positive for H5N1 avian influenza, marking the country’s third case of 2007.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»